Persistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality
Top Cited Papers
- 1 November 2014
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Shock
- Vol. 42 (5), 383-391
- https://doi.org/10.1097/shk.0000000000000234
Abstract
Objective: The objective of this study was to determine whether persistent lymphopenia on the fourth day following the diagnosis of sepsis predicts mortality. Methods: This was a single-center, retrospective cohort study of 335 adult patients with bacteremia and sepsis admitted to a large university-affiliated tertiary care hospital between January 1, 2010, and July 31, 2012. All complete blood cell count profiles during the first 4 days following the diagnosis of sepsis were recorded. The primary outcome was 28-day mortality. Secondary outcomes included development of secondary infections, 1-year mortality, and hospital and intensive care unit lengths of stay. Results: Seventy-six patients (22.7%) died within 28 days. Lymphopenia was present in 28-day survivors (median, 0.7 × 103 cells/μL; interquartile range [IQR], 0.4–1.1 × 103 cells/μL) and nonsurvivors (median, 0.6 × 103 cells/μL; IQR, 0.4–1.1 × 103 cells/μL) at the onset of sepsis and was not significantly different between the groups (P = 0.35). By day 4, the median absolute lymphocyte count was significantly higher in survivors compared with nonsurvivors (1.1 × 103 cells/μL [IQR, 0.7–1.5 × 103 cells/μL] vs. 0.7 × 103 cells/μL [IQR, 0.5–1.0 × 103 cells/μL]; P < 0.0001). Using logistic regression to account for potentially confounding factors (including age, Acute Physiology and Chronic Health Evaluation II score, comorbidities, surgical procedure during the study period, and time until appropriate antibiotic administration), day 4 absolute lymphocyte count was found to be independently associated with 28-day survival (adjusted odds ratio, 0.68 [95% confidence interval, 0.51–0.91]) and 1-year survival (adjusted odds ratio, 0.74 [95% confidence interval, 0.59–0.93]). Severe persistent lymphopenia (defined as an absolute lymphocyte count of 0.6 × 103 cells/μL or less on the fourth day after sepsis diagnosis) was associated with increased development of secondary infections (P = 0.04). Conclusions: Persistent lymphopenia on the fourth day following the diagnosis of sepsis predicts early and late mortality and may serve as a biomarker for sepsis-induced immunosuppression.Keywords
This publication has 43 references indexed in Scilit:
- Early alterations of B cells in patients with septic shockCritical Care, 2013
- Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis patternCritical Care, 2012
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ FailureJama-Journal Of The American Medical Association, 2011
- PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunctionCritical Care, 2010
- Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unitCritical Care, 2010
- The relationship between CD4+CD25+CD127- regulatory T cells and inflammatory response and outcome during shock statesCritical Care, 2010
- Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patientsCritical Care, 2009
- Downregulation of CD40 Ligand Response in Monocytes from Sepsis PatientsClinical and Vaccine Immunology, 2008
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care Medicine, 2003
- The Pathophysiology and Treatment of SepsisThe New England Journal of Medicine, 2003